Transpek Industry share price, P/E, ROE & financials

As of 6 Nov 2026, Transpek Industry trades at 18.3× trailing earnings, above the industry P/E of 18.2×, and the shares are 13% below their 52-week high. It earns ROCE of 7.8% and ROE of 6.0%, and sales and net profit fell 9.4% and 18% a year over 3 years. Its dividend yield is 1.6%. It is a small-cap company with a market cap of ₹715 Cr, ranked 35th of 76 Chemicals companies by market cap; the shares rose 7.7% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year

Open: ₹1,236.00
Day high: ₹1,299.00
Day low: ₹1,236.00
Prev. close: ₹1,261.10
Volume: 436

Health check

1 good · 2 fair · 3 to check

ReturnsAhead
+7.7% over a year, better than 5 of 7 peers.
Price tagIn line
P/E 18.3 vs industry 18.2.
GrowthShrinking
Sales −9.4%, profit −18.2% a year over 3 years.
ProfitabilityWeak
ROCE 7.8% vs peer median 10.6%.
Balance sheetFair
Piotroski 5 of 9.
Red flags3 to check
Return on equity is low at 6.0%.

Compared with 7 industry peers. Computed from reported figures. Educational, not a recommendation.

Chemicals

75 listed peers. Screen the industry

Small cap

₹715 Cr, #35 of 76 in its industry by size.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹618 Cr · profit ₹39 Cr

Market cap: ₹715 Cr; Small cap
P/E: 18.3; Industry 18.2
Price to book: 0.93; Peers 2.62
Dividend yield: 1.59%
ROE: 6.0%; Peers 11.7%
ROCE: 7.8%; Peers 10.6%
Debt to equity: n/a
EPS (TTM): ₹69.80; Face value ₹10
OPM (TTM): 14.5%; Net margin 6.3%
Sales growth: −2.1%; Latest quarter vs a year ago
Profit growth: −42.7%; Latest quarter vs a year ago
Price to sales: 1.16

Strengths

Positive operating cash flow in each of the last 4 years.

Risks to check

Return on equity is low at 6.0%.
Quarterly profit down 42.7% on a year ago.
Quarterly sales down 2.1% on a year ago.

Derived automatically from reported figures. Not a recommendation.

About Transpek Industry

Transpek Industry Limited manufactures and sells chemical products in India. The company offers 2, 4, 6 trimethyl benzoyl chloride, 2-chloroethylamine hydrochloride solution, 2-ethylhexanoyl chloride, 2-methoxyethyl chloride, 2-propoxyethyl chloride, 4-chlorobutyryl chloride, cocoyl chloride, diethylene glycol dichloride, isobutyryl chloride, isononanoyl chloride, isophthaloyl chloride, and lauroyl chloride. It also provides m-nitrobenzoyl chloride,…

Headquarters: Vadodara
Employees: 545
Sector: Basic Materials
ISIN: INE687A01016
Website: transpek.com

Price range

52 weeks

₹952.30₹1,475.00

Today

₹1,236.00₹1,299.00

Avg volume (3M): 2.8K
1-year return: plus 7.7%
From 52-week high: minus 13.2%

Peers · Chemicals

Capital-heavy industry columns

Compare with peers Screen the whole industry

Company
NAVINFLUORNavin Fluorine International	9,010.00	plus 1.87%	46,250	50.8	42.7	18.7%	34.3%	0.28	16.5%	plus 46.1%
DEEPAKNTRDeepak Nitrite	1,533.60	minus 0.67%	20,917	19.7	22.3	10.8%	18.0%	0.27	−0.5%	minus 11.9%
TATACHEMTata Chemicals	607.45	minus 1.36%	15,475	–	12.4	−3.0%	12.2%	0.36	−4.8%	minus 31.0%
DEEPAKFERTDeepak Fertilisers & Petrochemicals Corp.	1,155.30	minus 0.69%	14,599	14.8	11.5	11.2%	17.6%	0.76	2.6%	minus 22.7%
RPELRaghav Productivity Enhancers	1,780.80	plus 0.95%	8,178	116.0	107.1	–	29.9%	0.02	23.5%	plus 95.4%
GNFCGujarat Narmada Valley Fertilizers and Chemicals	451.80	minus 1.87%	6,639	6.3	5.4	10.4%	14.8%	0.01	−8.8%	minus 7.2%
ACIArchean Chemical Industries	416.40	minus 1.95%	5,141	51.3	23.2	7.7%	20.0%	0.28	−9.2%	minus 34.6%
TRANSPEKTranspek Industry	1,280.80	plus 1.56%	715	18.3	6.3	7.8%	14.5%	–	−9.4%	plus 7.7%
Median of 7 peers	–	−0.69%	14,599	35.2	22.3	10.6%	18.0%	0.28	−0.5%	−11.9%

Quarterly results

Consolidated, ₹ crore

SalesSelect a row below to chart it

Jun 25	Sep 25	Dec 25	Mar 26	Jun 26
154	160	158	148	151
130	134	134	130	131
24	26.7	24.9	17.7	20.1
15.6%	16.6%	15.7%	12.0%	13.3%
11.7	5	3.5	4.3	4
2.5	2.4	1.7	1.5	1.5
12.3	12.3	12.3	11.6	10.8
20.9	17	14.5	8.8	11.8
25.6%	25.5%	25.0%	25.5%	24.3%
15.6	12.6	10.8	6.6	8.9
27.90	22.62	19.42	11.78	15.98

Profit & loss

Yearly, ₹ crore

Sales CAGR 3Y: −9.4%
Profit CAGR 3Y: −18.2%
EPS CAGR 3Y: −18.2%
ROE: 6.0%

Net profitSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
826	580	648	615
–	minus 29.8%	+11.8%	minus 5.1%
662	497	536	508
164	82.3	112	107
19.9%	14.2%	17.3%	17.4%
0	24.5	17.9	8.5
15.4	14.4	9.8	6.8
33	37.6	50	48.6
−2.7	0.6	−8.5	0.9
113	55.5	61.7	61.2
26.0%	30.5%	21.0%	25.4%
83.5	38.6	48.7	45.6
–	minus 53.8%	+26.4%	minus 6.3%
149.45	69.03	87.25	81.72

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore

Total assetsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
5.6	5.6	5.6	5.6
581	668	740	762
145	123	94.5	74.4
155	169	161	166
887	966	1,001	1,008
391	404	365	348
26	6.3	5.7	4.8
250	333	333	317
24.8	29.7	105	114
195	193	192	225
887	966	1,001	1,008

Cash flow

Yearly, ₹ crore

Cash from operationsSelect a row below to chart it

Mar 2023	Mar 2024	Mar 2025	Mar 2026
111	97.8	135	78.5
−13	−31.5	−30.5	−37.5
−93.9	−63.7	−56.2	−39.7
3.9	2.6	48.4	1.3
−49.3	−39.6	−20.8	−38.2
61.5	58.2	114	40.2
−12.6	−15.4	−7.8	−11.2

Shareholding pattern

Source: NSE filings

NSE hasn’t returned a shareholding pattern for this company. Institutions hold about 0.0% (Yahoo estimate).

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you